Literature DB >> 31518403

Pulmonary vein isolation using ablation index vs. CLOSE protocol with a surround flow ablation catheter.

Benjamin Berte1, Gabriella Hilfiker1, Federico Moccetti1, Thomas Schefer1, Vanessa Weberndörfer1, Florim Cuculi1, Stefan Toggweiler1, Frank Ruschitzka2, Richard Kobza1.   

Abstract

AIMS: Pulmonary vein isolation (PVI) using ablation index (AI) incorporates stability, contact force (CF), time, and power. The CLOSE protocol combines AI and ≤6 mm interlesion distance. Safety concerns are raised about surround flow ablation catheters (STSF). To compare safety and effectiveness of an atrial fibrillation (AF) ablation strategy using AI vs. CLOSE protocol using STSF. METHODS AND
RESULTS: First cluster was treated using AI and second cluster using CLOSE. Procedural data, safety, and recurrence of any atrial tachycardia (AT) or AF >30 s were collected prospectively. All Classes 1c and III anti-arrhythmic drugs (AAD) were stopped after the blanking period. In total, all 215 consecutive patients [AI: 121 (paroxysmal: n = 97), CLOSE: n = 94 (paroxysmal: n = 74)] were included. Pulmonary vein isolation was reached in all in similar procedure duration (CLOSE: 107 ± 25 vs. AI: 102 ± 24 min; P = 0.1) and similar radiofrequency time (CLOSE: 36 ± 11 vs. AI: 37 ± 8 min; P = 0.4) but first pass isolation was higher in CLOSE vs. AI [left veins: 90% vs. 80%; P < 0.05 and right veins: 84% vs. 73%; P < 0.05]. Twelve-month off-AAD freedom of AF/AT was higher in CLOSE vs. AI [79% (paroxysmal: 85%) vs. 64% (paroxysmal: 68%); P < 0.05]. Only four patients (2%) without recurrence were on AAD during follow-up. Major complications were similar (CLOSE: 2.1% vs. AI: 2.5%; P = 0.87).
CONCLUSION: The CLOSE protocol is more effective than a PVI approach solely using AI, especially in paroxysmal AF. In this off-AAD study, 79% of patients were free from AF/AT during 12-month follow-up. The STSF catheter appears to be safe using conventional CLOSE targets. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation index; Atrial fibrillation; CLOSE protocol; Pulmonary vein isolation; Surround flow catheter

Mesh:

Year:  2020        PMID: 31518403     DOI: 10.1093/europace/euz244

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  The effect of left atrial wall thickness and pulmonary vein sizes on the acute procedural success of atrial fibrillation ablation.

Authors:  Melinda Boussoussou; Bálint Szilveszter; Borbála Vattay; Márton Kolossváry; Milán Vecsey-Nagy; Zoltán Salló; Gábor Orbán; Perge Péter; Piros Katalin; Nagy Klaudia Vivien; Osztheimer István; Pál Maurovich-Horvat; Béla Merkely; László Gellér; Nándor Szegedi
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-09       Impact factor: 2.357

2.  Two years after pulmonary vein isolation guided by ablation index-a multicenter study.

Authors:  Pedro A Sousa; Luís Puga; Luís Adão; João Primo; Ziad Khoueiry; Ana Lebreiro; Paulo Fonseca; Philippe Lagrange; Luís Elvas; Lino Gonçalves
Journal:  J Arrhythm       Date:  2022-03-15

3.  The impact of current strategy using intracardiac echocardiography, lesion index, and minimum substrate ablation on clinical outcomes after catheter ablation procedure for atrial fibrillation.

Authors:  Tetsuma Kawaji; Takanori Aizawa; Shun Hojo; Akihiro Kushiyama; Hidenori Yaku; Kenji Nakatsuma; Kazuhisa Kaneda; Masashi Kato; Takafumi Yokomatsu; Shinji Miki
Journal:  J Arrhythm       Date:  2021-08-05

4.  Fast anatomical mapping of the carina and its implications for acute pulmonary vein isolation.

Authors:  Dong-In Shin; Buelent Koektuerk; Hans P Waibler; Stephan List; Alexander Bufe; Melchior Seyfarth; Marc Horlitz; Christian Blockhaus
Journal:  J Arrhythm       Date:  2021-07-19

5.  Ablation for paroxysmal atrial fibrillation-real-life results from a middle-volume electrophysiology laboratory.

Authors:  Piotr Kulakowski; Agnieszka Sikorska; Roman Piotrowski; Tomasz Kryński; Jakub Baran
Journal:  J Interv Card Electrophysiol       Date:  2021-01-09       Impact factor: 1.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.